These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
63 related items for PubMed ID: 8632317
1. Modulation of seizure activity in mice by metabotropic glutamate receptor ligands. Dalby NO, Thomsen C. J Pharmacol Exp Ther; 1996 Feb; 276(2):516-22. PubMed ID: 8632317 [Abstract] [Full Text] [Related]
2. (S)-4-carboxy-3-hydroxyphenylglycine, an antagonist of metabotropic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice. Thomsen C, Klitgaard H, Sheardown M, Jackson HC, Eskesen K, Jacobsen P, Treppendahl S, Suzdak PD. J Neurochem; 1994 Jun; 62(6):2492-5. PubMed ID: 8189254 [Abstract] [Full Text] [Related]
3. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability. Ornstein PL, Bleisch TJ, Arnold MB, Kennedy JH, Wright RA, Johnson BG, Tizzano JP, Helton DR, Kallman MJ, Schoepp DD, Hérin M. J Med Chem; 1998 Jan 29; 41(3):358-78. PubMed ID: 9464367 [Abstract] [Full Text] [Related]
4. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ. J Pharmacol Exp Ther; 1999 Jun 29; 289(3):1678-87. PubMed ID: 10336568 [Abstract] [Full Text] [Related]
5. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors. Thomsen C, Bruno V, Nicoletti F, Marinozzi M, Pellicciari R. Mol Pharmacol; 1996 Jul 29; 50(1):6-9. PubMed ID: 8700119 [Abstract] [Full Text] [Related]
6. Roles of metabotropic glutamate receptor subtypes in modulation of pentylenetetrazole-induced seizure activity in mice. Thomsen C, Dalby NO. Neuropharmacology; 1998 Dec 29; 37(12):1465-73. PubMed ID: 9886669 [Abstract] [Full Text] [Related]
7. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid, a potent mGluR1 antagonist. Moroni F, Lombardi G, Thomsen C, Leonardi P, Attucci S, Peruginelli F, Torregrossa SA, Pellegrini-Giampietro DE, Luneia R, Pellicciari R. J Pharmacol Exp Ther; 1997 May 29; 281(2):721-9. PubMed ID: 9152378 [Abstract] [Full Text] [Related]
11. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex. Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD. J Pharmacol Exp Ther; 1996 Nov 20; 279(2):492-501. PubMed ID: 8930150 [Abstract] [Full Text] [Related]
12. The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration. Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Taracha E, Skórzewska A, Lehner M, Bidziński A, Hamed A, Wisłowska-Stanek A, Płaźnik A. Brain Res; 2009 Jul 28; 1282():20-7. PubMed ID: 19481536 [Abstract] [Full Text] [Related]
13. Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons. Montoliu C, Llansola M, Cucarella C, Grisolía S, Felipo V. J Pharmacol Exp Ther; 1997 May 28; 281(2):643-7. PubMed ID: 9152368 [Abstract] [Full Text] [Related]
14. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats. Celuch SM, García Mdel C. Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct 28; 366(4):343-9. PubMed ID: 12237748 [Abstract] [Full Text] [Related]
15. Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia. Robbins MJ, Starr KR, Honey A, Soffin EM, Rourke C, Jones GA, Kelly FM, Strum J, Melarange RA, Harris AJ, Rocheville M, Rupniak T, Murdock PR, Jones DN, Kew JN, Maycox PR. Brain Res; 2007 Jun 04; 1152():215-27. PubMed ID: 17434465 [Abstract] [Full Text] [Related]
16. Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus. Losonczy A, Somogyi P, Nusser Z. J Neurophysiol; 2003 Apr 04; 89(4):1910-9. PubMed ID: 12686572 [Abstract] [Full Text] [Related]
17. Anticonvulsant and neuroprotective effect of (S)-3,4-dicarboxyphenylglycine against seizures induced in immature rats by homocysteic acid. Folbergrová J, Druga R, Haugvicová R, Mares P, Otáhal J. Neuropharmacology; 2008 Mar 04; 54(4):665-75. PubMed ID: 18191956 [Abstract] [Full Text] [Related]
18. Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. Steppuhn KG, Turski L. J Pharmacol Exp Ther; 1993 Jun 04; 265(3):1063-70. PubMed ID: 8509995 [Abstract] [Full Text] [Related]
19. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes. Nishi N, Odagaki Y, Koyama T. Br J Pharmacol; 2000 Aug 04; 130(7):1664-70. PubMed ID: 10928972 [Abstract] [Full Text] [Related]
20. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. Hayashi Y, Sekiyama N, Nakanishi S, Jane DE, Sunter DC, Birse EF, Udvarhelyi PM, Watkins JC. J Neurosci; 1994 May 04; 14(5 Pt 2):3370-7. PubMed ID: 8182479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]